CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award | +6,104 | 33,144 | ||
| 2020-02-25 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award · Employee Stock Options (Right to Buy) | +24,414 | $61.44 | $1.5M | 44,735 |
| 2020-02-25 | Kramer Robert President and CEO | Grant or award | +16,683 | 128,077 | ||
| 2020-02-25 | Kramer Robert President and CEO | Grant or award | +16,683 | 144,760 | ||
| 2020-02-25 | Kramer Robert President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +66,731 | $61.44 | $4.1M | 113,928 |
| 2020-02-25 | El-Hibri Fuad Chairman | Option exercise | +6,010 | 1,485,028 | ||
| 2020-02-25 | El-Hibri Fuad Chairman | Grant or award · Employee Stock Options (Right to Buy) | +39,061 | 39,061 | ||
| 2020-02-25 | El-Hibri Fuad Chairman | Grant or award · Restricted Stock Unit | +19,532 | 60,213 | ||
| 2020-02-25 | El-Hibri Fuad Chairman | Option exercise · Restricted Stock Unit | −6,010 | 54,203 | ||
| 2020-02-21 | Richard Ronald Director | Option exercise | +5,152 | $18.64 | $96K | 31,851 |
| 2020-02-21 | Richard Ronald Director | Sale | −5,152 | $65.00 | $335K | 16,395 |
| 2020-02-21 | Richard Ronald Director | Option exercise · Employee Stock Options (Right to Buy) | −5,152 | $18.64 | $96K | 7,893 |
| 2020-02-21 | Hauer Jerome M Director | Sale | −6,572 | $70.00 | $460K | 11,752 |
| 2020-02-21 | El-Hibri Fuad Chairman | Option exercise | +18,567 | $25.62 | $476K | 1,497,585 |
| 2020-02-21 | El-Hibri Fuad Chairman | Sale | −18,567 | $64.90 | $1.2M | 1,479,018 |
| 2020-02-21 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −18,567 | 0 | ||
| 2020-02-20 | El-Hibri Fuad Chairman | Option exercise | +4,751 | $25.62 | $122K | 1,483,769 |
| 2020-02-20 | El-Hibri Fuad Chairman | Sale | −4,751 | $64.90 | $308K | 1,479,018 |
| 2020-02-20 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −4,751 | 18,567 | ||
| 2020-02-18 | El-Hibri Fuad Chairman | Option exercise | +15,614 | $25.62 | $400K | 1,494,632 |
Page 29 of 31 · 601 trades